[Influence of 2-dimethylaminoethanol in correcting the asthenic and nervous symptoms of sideropenic patients].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000747:Anemia, Hypochromic / Q000150:complications* / Q000188:drug therapy; D001120:Arginine / Q000627:therapeutic use; D001247:Asthenia / Q000188:drug therapy / Q000209:etiology; D001729:Bismuth / Q000008:administration & dosage; D003642:Deanol / Q000627:therapeutic use*; D004492:Edetic Acid / Q000627:therapeutic use; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007501:Iron / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009132:Muscles; D009422:Nervous System Diseases / Q000188:drug therapy / Q000209:etiology*; D009942:Organometallic Compounds; D014020:Tissue Extracts / Q000627:therapeutic use
D004983:Ethanolamines; D009942:Organometallic Compounds; D014020:Tissue Extracts; D003642:Deanol; D001120:Arginine; D004492:Edetic Acid; D007501:Iron; C002791:bismuth tripotassium dicitrate; D001729:Bismuth
L'influenza del 2-dimetilaminoetanolo nel correggere la sintomatologia astenico-nervosa del paziente sideropenico.